Indegene to Acquire the Multi-channel, e-Detailing and Physician Marketing Services Business Assets of Canada-based Aptilon, to Help Clients Accelerate Their Physician Engagement Strategies

ISELIN, New Jersey, November 9, 2012 /PRNewswire/ –

Indegene, a leading provider of R&D, commercial and marketing solutions to top global
pharmaceutical and healthcare organizations, today announced a definitive agreement to
acquire the multi-channel, video and e-detailing, and physician marketing services
business of Aptilon Holdings Inc., a wholly owned subsidiary of Aptilon Corporation.

(Logo:
http://photos.prnewswire.com/prnh/20120820/554732 )

Aptilon, headquartered in Canada, is a pioneer and a leader in providing e-marketing
solutions for several large pharmaceutical, biotech and healthcare clients in the United
States, Canada and Europe. Aptilon enables clients to effectively reach, connect and
interact with over 500,000 physicians and healthcare professionals via multiple access
channels including iPADs, mobile and desktop media. Its innovative service and platform
offerings, including Live Central and Channel HQ, provide targeted impressions and
interactions through “click-to-talk” video and mobile detailing, digital access
“on-demand” channels and permission-based e-mail services that drive efficient physician
recruitment and outcomes.

The need for intelligent, robust, and outcome-driven multi-channel marketing (MCM) and
Virtual/Inside Sales programs is estimated to represent a USD 10 billion opportunity as
companies continue to accelerate the transformation of their sales and marketing
organizations over the next 4-5 years.

Manish Gupta, CEO, Indegene, said: “By combining Indegene’s Virtual/Inside Sales and
MCM capabilities with Aptilon’s technology platforms, significant physician reach, and
multi-year data on physician behavior in the North American and European market, clients
can accelerate their physician engagement strategies and deploy true end-to-end
world-class programs.”

Denis Martineau, President, Aptilon Holdings Inc., added: “Aptilon has been a leading
provider of world-class e-marketing, remote detailing and multi-channel marketing
programs. Through this proposed transaction, our clients will gain access to an
accelerated approach to drive integrated physician engagement programs. In addition, our
clients can leverage global expertise and infrastructure assets in US, Europe and Emerging
Markets to enhance productivity as well as effectiveness.”

Upon completion of the acquisition, Aptilon’s multi-channel, e-detailing, and
physician marketing services businesses will be rolled under Indegene Aptilon, Inc. – a
wholly-owned subsidiary of Indegene Lifesystems Pvt. Ltd.

Dr. Rajesh Nair, President, Indegene, said: “Indegene has been a leading provider of
digital and multi-channel marketing solutions to global pharma since early adopters
started to transform their sales and marketing organizations. We have implemented close to
100 global and local programs, and now have over 300 full-time MCM and Virtual/Inside
sales professionals based in US, India and China. We have also added over 20 strategic
contact center partnerships globally to enable clients to deploy
multi-country/multi-regional/multi-lingual sales and MCM programs for both new and mature
products.”

Dr. Nair added: “This acquisition presents us with a unique opportunity to further
consolidate our Virtual/Inside sales offering. We expect the synergies of this acquisition
to create around 200 new jobs

in USA and Canada, and an additional 1,000 jobs in India and China as we ramp up to
address this need. We expect to complete this transaction in the next few weeks subject to
customary closing conditions including obtaining necessary approvals from regulatory
authorities.”

About Indegene

Indegene is a leading provider of R&D, commercial and marketing solutions to global
pharmaceutical and healthcare organizations. We partner with clients to drive both
productivity and revenues by delivering better patient outcomes, optimizing cost,
enhancing R&D agility, and improving sales and marketing effectiveness. We apply deep
scientific knowledge, flexible delivery models, proprietary technology, and a
client-centric approach to drive transformational initiatives.

With offices in US, UK, China, India, and Australia, Indegene can partner globally
with clients; leverage a global talent pool of clinicians, technologists, creative
specialists, domain experts, and business process specialists; deploy global
infrastructure assets; and harness global healthcare knowledge to solve client challenges.
For more information, visit http://www.indegene.com.

About Aptilon

Aptilon enables pharmaceutical, biotech and medical device companies to effectively
reach, message, connect, and interact with US physicians and healthcare professionals via
multiple access channels. Its innovative service offerings provide targeted impressions
and interactions through video and mobile detailing, digital access channels and
permission-based e-mail services. Top pharmaceutical companies and respected healthcare
organizations have adopted Aptilon’s solutions to market to, engage and interact with
leading healthcare practitioners. For more information, visit

http://www.indegeneaptilon.com.

        US and Europe
        Ann Marie Craggan
        Indegene Inc.
        Phone: +1-732-750-2901
        e-mail: ann-marie.craggan@indegene.com [eann-marie.craggan@indegene.com ]

        Asia Pacific
        Sherin Varghese
        Genesis Burson-Marsteller
        Mobile: +91-99161-15584
        e-mail: sherin.varghese@bm.com [esherin.varghese@bm.com ]

    Photo: 

http://photos.prnewswire.com/prnh/20120820/554732

SOURCE Indegene Lifesystems Pvt Ltd